Monoclonal gammopathy of undetermined significance causes
|
Monoclonal gammopathy of undetermined significance Microchapters |
|
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Monoclonal gammopathy of undetermined significance causes On the Web |
|
American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance causes |
|
FDA on Monoclonal gammopathy of undetermined significance causes |
|
on Monoclonal gammopathy of undetermined significance causes |
|
Monoclonal gammopathy of undetermined significance causes in the news |
|
Blogs on Monoclonal gammopathy of undetermined significance causes |
|
Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance |
|
Risk calculators and risk factors for Monoclonal gammopathy of undetermined significance causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
The most common causes of monoclonal gammopathy of undetermined significance classification are genetic mutations in genes like cyclin D1, FGFR-3, MMSET, C-MAF, and MAFB.
Causes
The most common causes of monoclonal gammopathy of undetermined significance classification are genetic mutations. However, there is no established cause of progression of multiple myeloma to monoclonal gammopathy of undetermined significance classification.
Genetic causes[1]
| Abnormalities in cytogenes | Affected genes |
| IgH translocation: | |
| t(11;14), q(13;32) | cyclin D1 |
| t(4;14)(p16;q32) | FGFR-3, and MMSET |
| t(14;16)(q32;q23) | C-MAF |
| t(6;14)(q32;q11) | MAFB |
| IgH non-translocated : | |
| Hyper diploid | Numerous |
References
- ↑ Mikulasova A, Wardell CP, Murison A, Boyle EM, Jackson GH, Smetana J, Kufova Z, Pour L, Sandecka V, Almasi M, Vsianska P, Gregora E, Kuglik P, Hajek R, Davies FE, Morgan GJ, Walker BA (September 2017). "The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma". Haematologica. 102 (9): 1617–1625. doi:10.3324/haematol.2017.163766. PMC 5685224. PMID 28550183.